Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Regen BioPharma Inc RGBP

Regen BioPharma Inc. is a biotechnology company. The Company is engaged on the immunology and immunotherapy space. The Company is focused on novel technologies through pre-clinical and Phase I/ II clinical trials. It is involved on mRNA and small molecule therapies for treating cancer and autoimmune disorders. It is also developing products treating blood disorders using small molecules and... see more

Recent & Breaking News (OTCPK:RGBP)

Regen BioPharma, Inc. Expands Vision for Phase 1 Clinical Trial of HemaXellerate(TM)

GlobeNewswire 6 days ago

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on September 25, 2024, At 4 pm Eastern Time

GlobeNewswire September 23, 2024

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on May 9, 2024

PR Newswire May 7, 2024

Regen BioPharma, Inc. to Discuss Plans to Move Forward with HemaXellerate into Clinical Phase 1 at the Emerging Growth Conference on April 4, 2024

PR Newswire April 2, 2024

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on March 7, 2024

PR Newswire March 5, 2024

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on February 7, 2024

PR Newswire February 5, 2024

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on January 10, 2024

PR Newswire January 8, 2024

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on December 7, 2023

PR Newswire December 5, 2023

Regen BioPharma, Inc. Selects Contract Research Organization to Assist in DuraCAR Experiments

PR Newswire November 16, 2023

Regen BioPharma, Inc. CEO Outlines Future Steps in CAR T Program

PR Newswire November 14, 2023

Regen BioPharma, Inc. to Discuss Confirmation Study Results on Its DuraCar Program at the Emerging Growth Conference on November 1, 2023

PR Newswire October 30, 2023

Regen BioPharma, Inc. Receives Second Phase Confirmatory Data on its Duracar CAR-T Cell Therapy Program

PR Newswire October 25, 2023

Regen BioPharma, Inc. Expects Second Phase of Confirmatory Study Shortly

PR Newswire October 18, 2023

Regen BioPharma, Inc. Receives First Phase of Confirmatory Study

PR Newswire October 10, 2023

Goldman Small Cap Research Publishes New Research Report on Regen BioPharma, Inc.

Accesswire October 4, 2023

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on October 5, 2023

PR Newswire October 3, 2023

Studies On Regen BioPharma, Inc.'s DURACAR Indicate Potential Suppression Of Autoimmunity, Company Retains Contract Research Organization To Conduct Additional Confirmatory Studies

PR Newswire September 19, 2023

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on September 6, 2023

PR Newswire September 6, 2023

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on August 10, 2023

PR Newswire August 8, 2023

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on March 3, 2023

PR Newswire March 7, 2023